Literature DB >> 16860730

Cell cycle: sustained ERK signalling represses the inhibitors.

Andrew D Sharrocks1.   

Abstract

The duration of ERK pathway signalling determines the proliferative response of cells. A recent study has shown that cell cycle re-entry requires the downregulation of an anti-proliferative gene cluster following sustained activation of the ERK pathway.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16860730     DOI： 10.1016/j.cub.2006.06.038

Source DB:  PubMed          Journal:  Curr Biol        ISSN： 0960-9822            Impact factor:   10.834


  17 in total

Review 1.  Signaling through the P38 and ERK pathways: a common link between HIV replication and the immune response.

Authors:  Robert L Furler; Christel H Uittenbogaart
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

2.  Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1 signaling.

Authors:  Seiji Mori; Chun-Yi Wu; Satoshi Yamaji; Jun Saegusa; Biao Shi; Zi Ma; Yasuko Kuwabara; Kit S Lam; R Rivkah Isseroff; Yoko K Takada; Yoshikazu Takada
Journal:  J Biol Chem       Date:  2008-04-25       Impact factor: 5.157

Review 3.  Regulation of primary response genes.

Authors:  Trent Fowler; Ranjan Sen; Ananda L Roy
Journal:  Mol Cell       Date:  2011-11-04       Impact factor: 17.970

4.  Biomaterial-enabled delivery of SDF-1α at the ventral side of breast cancer cells reveals a crosstalk between cell receptors to promote the invasive phenotype.

Authors:  Xi Qiu Liu; Laure Fourel; Fabien Dalonneau; Rabia Sadir; Salome Leal; Hugues Lortat-Jacob; Marianne Weidenhaupt; Corinne Albiges-Rizo; Catherine Picart
Journal:  Biomaterials       Date:  2017-02-27       Impact factor: 12.479

Review 5.  Targeting ERK beyond the boundaries of the kinase active site in melanoma.

Authors:  Rachel M Sammons; Ranajeet Ghose; Kenneth Y Tsai; Kevin N Dalby
Journal:  Mol Carcinog       Date:  2019-06-12       Impact factor: 4.784

6.  A novel fibroblast growth factor-1 (FGF1) mutant that acts as an FGF antagonist.

Authors:  Satoshi Yamaji; Jun Saegusa; Katsuaki Ieguchi; Masaaki Fujita; Seiji Mori; Yoko K Takada; Yoshikazu Takada
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

7.  Aberrant receptor internalization and enhanced FRS2-dependent signaling contribute to the transforming activity of the fibroblast growth factor receptor 2 IIIb C3 isoform.

Authors:  Jiyoung Y Cha; Savitri Maddileti; Natalia Mitin; T Kendall Harden; Channing J Der
Journal:  J Biol Chem       Date:  2008-12-22       Impact factor: 5.157

8.  Brk is coamplified with ErbB2 to promote proliferation in breast cancer.

Authors:  Bin Xiang; Kiranam Chatti; Haoqun Qiu; B Lakshmi; Alexander Krasnitz; Jim Hicks; Min Yu; W Todd Miller; Senthil K Muthuswamy
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

9.  An integrative model links multiple inputs and signaling pathways to the onset of DNA synthesis in hepatocytes.

Authors:  Jérémy Huard; Stephanie Mueller; Ernst D Gilles; Ursula Klingmüller; Steffen Klamt
Journal:  FEBS J       Date:  2012-04-10       Impact factor: 5.542

10.  Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma.

Authors:  Zhou Luan; Ying He; Mohamed Alattar; Zhishui Chen; Fan He
Journal:  Mol Cancer       Date:  2014-02-25       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.